Despite substantial investments in groundbreaking treatments, companies struggle to communicate value early and to the right ...

Knowable Magazine shares how studies show psychological strain can accelerate tumors and asks if beta blockers slow them down ...

From Otter to Zoom, voice AI is reshaping meetings, notes, and workflows. Discover how these tools are streamlining — or ...

By targeting these pathways with drugs, we might be able to directly kill cancer cells-or to enhance the immune system's ...

Researchers have created over 3,800 ‘digital twins’ of human hearts to study how cardiac disease varies across age groups, ...

Potential treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases may already be out there in ...

On May 30, a team of researchers funded by the National Institutes of Health got the word: Funding for their vaccine ...

Dr. Bruce Chabner explains how clinical trials pave the way for new treatments and the benefits of participating in one.

The gap between what's being sold and what's supported by robust scientific evidence is widening, says to Professor Sarah ...

Author Abdi Nazemian joins Yahoo's Queer Voices to discuss his book Like a Love Story, why book banning is an issue, and how to fight back.

TuHURA Biosciences said its carcinoma therapy trials can continue now that health regulators have removed the partial clinical hold on the treatment tests.

One-size-fits-all hats are okay, but one-size-fits-all medical treatments don't cut it. A new study shows that drug treatment ...